Half of newly developed drugs are the result of this 1983 Law

  “Orphan” drugs were once a market almost no company wanted. Four decades later, they make up more than half of the new drugs the Food and Drug Administration approves. In 2024, the FDA’s drug center approved 50 new medicines. More than half of them (26 in all) were built to treat a rare disease.